Singapore-based CBC Group and Europe’s GHO Capital have signed a definitive agreement to merge, forming the world’s largest dedicated healthcare investment platform with over USD 21 billion in assets under management. The combined entity will span Asia-Pacific, Europe, and North America — regions accounting for approximately 90% of global healthcare R&D spend — with 13 offices and more than 200 professionals. The merger is expected to close in early 2027, pending regulatory approvals.

The platform will be led by CBC CEO Wei Fu and GHO co-founder Mike Mortimer as co-CEOs, with Wei Fu and GHO co-founder Mireille Gillings serving as co-chairs. The merger aims to provide portfolio companies with enhanced global operational support across biopharma, medtech and healthcare infrastructure, while offering investors diversified access to private equity, credit and royalty opportunities.

PharmCube's MedAlpha® database shows that CBC alone has participated in 25 healthcare-related funding events since 2014, totalling USD 2.4 billion in reported funding. Click here to request a free trial for MedAlpha®.